IL5 and thalassemia: This is because it is believed that patients with thalassemia have increased plasma malondialdehyde and circulating non-transferrin bound iron (NTBI) relative to patients with SCD, and lower levels of some cytokines (interleukin 5 and interleukin 10) and γ-tocopherol (36).